Log In
BCIQ
Print this Print this
 

arimoclomol (OR-04)

  Manage Alerts
Collapse Summary General Information
Company Orphazyme ApS
DescriptionOral small molecule heat shock response inducer
Molecular Target Heat shock protein 70 (Hsp70)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat superoxide dismutase 1 (SOD1) linked familial amyotrophic lateral sclerosis (FALS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today